Two previous studies demonstrated that ATO and/or ATRA could induce proteasome-mediated degradation of mutant NPM1 in AML cell lines and primary samples, leading to differentiation and apoptosis [59, 60]. Here, NPM1 is linked to acute myeloid leukemia.